(Published in Part II, Section 3, Sub-section (ii) of
the Gazette of India, Extraordinary, dated the 27th September, 2007)
Government of India
Ministry of Chemicals and Fertilizers
National Pharmaceutical Pricing Authority
New Delhi, the 27th September, 2007
ORDER
S.O. 1667(E)- In exercise of the powers, conferred by sub-paragraph (1)/(2)/(4) of paragraph 8 of the Drugs (Price Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority hereby fixes/revises the prices as specified in column (5) of the Table hereto annexed as the retail price/revised retail price, exclusive of excise duty, sales taxes/VAT and local taxes, if any, and in column (6) equivalent MRP inclusive of excise duty, education cess, sales tax / VAT in relation to each of the formulations specified in the corresponding entry in column (2) of the said Table with pack size specified in the corresponding entries in column (3) thereof; manufactured/imported by M/s. Sanofi Aventis
TABLE
| Sl. No. | Name of the formulation | Pack Size | Existing Retail Price (Rs.) |
Retail Price without Excise Duty Sales Tax /VAT and Local Tax, if any (Rs.) |
Equivalent MRP* inclusive of all taxes (Rs.) |
| (1) | (2) | (3) | (4) | (5) | (6) |
| “1. |
Insuman 25/75 H-Insulin-40 IU/ML Recombinant DNA Origin Batch No. 40B086 Qty. 50400 Vials Batch No. 41B086 Qty. 42830 Vials Batch No. 40B087Qty. 51870 Vials |
10ml Vial | 237.15 | 191.89 | 199.56 |
| 2. |
Insuman basal H- Insulin 40 IU/ml Recombinant DNA Origin Batch No. 40B048 Qty. 5000 Vials |
10ml Vial | 237.15 | 191.89 | 199.56 |
| 3. |
Lantus 100 IU Cartridge Monocomponent Insulin Glargine Batch No. 40N403 Qty. 12000 Batch No. 40N414 Qty. 42050 Batch No. 40B433 Qty. 24000 Batch No. 40N403 Qty. 7425 Batch No. 40N421 Qty. 3725 Batch No. 40N422 Qty. 18225 |
3ml Cartridge | 464.70 | 481.35 | 524.67” |
*Subject to actual payment of Government levies/taxes, as applicable.
Note :
(a) The prices fixed are the maximum retail prices in column no. (6) (inclusive of excise duty, sales tax/VAT and local taxes if any) for the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(b) The companies / manufacturers may added taxes only if they have paid actually to the Government on the price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in the Form-V of DPCO, 1995.
(c) For different packing material used or any special feature claimed, companies are required to approach NPPA for approval/fixation of specific prices.
(d) These prices/revised prices shall be made effective within 15 days of receipt of this order as required under sub para 14(1) of DPCO, 1995. The necessary price-list should also be issued as required under sub-paragraph (3) of paragraph 14 of the Drugs (Prices Control) Order, 1995.
(e) The manufacturer and marketing company for the above said formulation shall be required to take the requisite prior approval from the competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
PN/96/2007/F F. No. 8(6)/2007/D.P./NPPA-Div.-II
(A. K. PAL)
Deputy Director
Last Page Updated: 22-10-2018
